Add Yahoo as a preferred source to see more of our stories on Google. Viagra, the little blue pill, has been a household name for more than a generation. And now women’s sexual health is finally ...
You may have heard about Addyi (flibanserin), a nonhormonal medicine approved by the FDA to treat low sex drive, also called hypoactive sexual desire disorder (HSDD) in women less than 65 years old.
We need to talk about desire. Specifically, why women are accepting a subpar sex life in midlife and beyond. I know it’s felt ...
Addyi, sometimes referred to as "female Viagra," is now approved for use to treat low sex drive in postmenopausal women. MoMo Productions/Getty Images The Food and Drug Administration (FDA) expanded ...
Share on Pinterest The FDA has expanded its approval of a libido-boosting drug to postmenopausal women. Xvision/Getty Images On December 15, 2025, the U.S. FDA approved Addyi (flibanserin) for the ...
Add Yahoo as a preferred source to see more of our stories on Google. Addyi is the brand name for a prescription drug that treats hypoactive sexual desire disorder (HSDD), the medical term for low sex ...
Addyi (flibanserin) is prescribed to treat low sex drive, also called hypoactive sexual desire disorder (HSDD), in women younger than 65 years. Women with HSDD struggle with an ongoing lack of ...
For decades, medicine largely treated sexual dysfunction as a male problem. Drugmakers developed treatment after treatment for men, filling pharmacy shelves and television commercials with products ...
Digital Journal reported on August 18, 2015, that Addyi, a drug that works on the brain to boost younger women’s libido if they have lost interest in sex, was given approval by the Food and Drug ...
INDIANAPOLIS (WISH) — This week, the Food and Drug Administration approved Addyi, the first medication for low libido in women younger than 65 years of age. Low libido affects 1 in 8 postmenopausal ...
Viagra, the little blue pill, has been a household name for more than a generation. And now women's sexual health is finally entering the long-overdue conversation. The FDA recently approved the use ...